Insufficient scRNA-seq data for expression of CYP39A1 at single-cell level.
Insufficient scRNA-seq data for expression of CYP39A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 621.01 | 241 / 245 | 100% | 41.93 | 501 / 502 |
ovary | 100% | 737.33 | 180 / 180 | 84% | 4.84 | 361 / 430 |
thymus | 99% | 396.81 | 644 / 653 | 85% | 9.32 | 512 / 605 |
intestine | 96% | 218.58 | 932 / 966 | 81% | 9.54 | 428 / 527 |
uterus | 98% | 269.36 | 166 / 170 | 68% | 4.38 | 312 / 459 |
liver | 100% | 1575.54 | 226 / 226 | 65% | 11.84 | 265 / 406 |
pancreas | 98% | 227.79 | 320 / 328 | 61% | 3.41 | 109 / 178 |
esophagus | 99% | 450.44 | 1431 / 1445 | 59% | 4.25 | 108 / 183 |
kidney | 99% | 267.62 | 88 / 89 | 58% | 3.83 | 526 / 901 |
lung | 92% | 229.68 | 531 / 578 | 64% | 4.34 | 744 / 1155 |
stomach | 91% | 270.49 | 327 / 359 | 65% | 7.01 | 186 / 286 |
bladder | 95% | 275.67 | 20 / 21 | 57% | 5.00 | 287 / 504 |
skin | 85% | 743.98 | 1532 / 1809 | 57% | 5.36 | 271 / 472 |
breast | 90% | 213.81 | 413 / 459 | 47% | 4.27 | 528 / 1118 |
adrenal gland | 94% | 209.69 | 243 / 258 | 29% | 2.25 | 66 / 230 |
heart | 84% | 174.16 | 723 / 861 | 0% | 0 | 0 / 0 |
brain | 60% | 99.86 | 1592 / 2642 | 24% | 1.02 | 166 / 705 |
adipose | 77% | 194.57 | 931 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 68% | 91.91 | 905 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 3.20 | 27 / 45 |
spleen | 24% | 27.51 | 59 / 241 | 0% | 0 | 0 / 0 |
muscle | 9% | 9.71 | 73 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.38 | 6 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.39 | 1 / 29 |
peripheral blood | 0% | 0.35 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0016125 | Biological process | sterol metabolic process |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0006707 | Biological process | cholesterol catabolic process |
GO_0007586 | Biological process | digestion |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0033782 | Molecular function | 24-hydroxycholesterol 7alpha-hydroxylase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0008396 | Molecular function | oxysterol 7-alpha-hydroxylase activity |
GO_0020037 | Molecular function | heme binding |
GO_0008387 | Molecular function | steroid 7-alpha-hydroxylase activity |
Gene name | CYP39A1 |
Protein name | Cytochrome P450 family 39 subfamily A member 1 24-hydroxycholesterol 7-alpha-hydroxylase (EC 1.14.14.26) (Cytochrome P450 39A1) (hCYP39A1) (Oxysterol 7-alpha-hydroxylase) |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in neural cholesterol clearance through bile acid synthesis . Catalyzes 7-alpha hydroxylation of (24S)-hydroxycholesterol, a neural oxysterol that is metabolized to bile acids in the liver . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) . . |
Accessions | Q9NYL5 A0A087WTD2 ENST00000619708.4 ENST00000275016.3 |